Carter Percy H.'s Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Jun 5, 2025
- Accession no.
- 0001415889-25-015767
- Filed
- Jun 5, 2025
- Trade date
- Jun 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $340.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carter Percy H.CIK 0001863024 | Officer (CHIEF SCIENTIFIC OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Common Stock | SSaleDisposed | −241 | $127.88 | −$30,819.08 | 56,624 | Direct | |
| Jun 3, 2025 | Common Stock | SSaleDisposed | −2,418 | $127.88 | −$309,213.84 | 54,206 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.